1-(6-(Dimethylamino)pyridin-3-yl)-2,2,2-trifluoroethan-1-one, 95+%, 50mg

Lucitanib, 98.94%, 1mg

3-chloro-1,2-benzisothiazole 1,1-dioxide, 95.0%, 10g

(R)-2-(4-(Trifluoromethyl)phenyl)pyrrolidine hydrochloride, 95.0%, 250mg

5-cyclopropyl-4-(tetrahydrofuran-2-ylmethyl)-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

2-(3-BROMO-4,5-DIMETHYLPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95%, 100mg

Pentadecane>99.0%(GC)500mL

cis-5-Octen-1-ol>90.0%(GC)5mL

1-(4-Fluoro-3-methylphenyl)ethan-1-amine, 95%, 250mg

3-[4-Chloro-2-(trifluoromethyl)phenyl]propionic acid, 5g

BENZYLDIMETHYL(OCTADECYL)AMMONIUM CHLORIDE, 98%, 25g

Solución estándar de AAS de silicio, ROTI®Star, 1000 mg/l Si, densidad (D) 1 g/cm³

4-CHLORO-7-FLUORO-2-METHYLQUINOLINE, 98%, 5g